Immunotherapy in patients who have NSCLC without EGFR or ALK mutations.

Immunotherapy in patients who have NSCLC without EGFR or ALK mutations. Clin Adv Hematol Oncol. 2018 Jul;16(7):484-485 Authors: Gandhi L PMID: 30067619 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/30067619?dopt=Abstract

Source: Clinical Advances in Hematology and Oncology - August 3, 2018 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research

More News: Cancer & Oncology | Hematology | Immunotherapy | Non-Small Cell Lung Cancer